The FDA has approved an application to market the emergency contraceptive Plan B One-Step for use without a prescription by women 15 years of age and older.
The US Food and Drug Administration (FDA) announced that it has approved an application submitted by Teva Women’s Health to market the emergency contraceptive Plan B One-Step (levonorgestrel) for use without a prescription by women 15 years of age and older. In December 2011, Teva had submitted an application to make Plan B One-Step available over the counter (OTC) to all girls of reproductive age, however at that time the FDA did not approve the application.
This approval is based on an actual use study and label comprehension data submitted by Teva showing that women age 15 and older understood that the product was not for routine use and would not protect them against sexually transmitted diseases. The FDA stated that “Plan B One-Step will be packaged with a product code prompting a cashier to request and verify the customer’s age. A customer who cannot provide age verification will not be able to purchase the product.” To prevent theft, a security tag will be placed on all product cartons of Plan B One-Step.
“Research has shown that access to emergency contraceptive products has the potential to further decrease the rate of unintended pregnancies in the United States,” said FDA Commissioner Margaret A. Hamburg, MD. “The data reviewed by the agency demonstrated that women 15 years of age and older were able to understand how Plan B One-Step works, how to use it properly, and that it does not prevent the transmission of a sexually transmitted disease.”
Besides Plan B One-Step, there are currently two other emergency contraceptive drugs available in the United States: Plan B and ella. Plan B is a prescription contraceptive that is available from generic manufacturers for women over the age of 17. It is comprised of two doses of levonorgestrel (.75 mg in each tablet) taken 12 hours apart. Ella (ulipristal) also requires a prescription, and prevents pregnancy when taken orally within 5 days after unprotected sexual intercourse.
Plan B One-Step will not stop a pregnancy when a woman is already pregnant, and there is no medical evidence that the product will harm a developing fetus.
Recap on reproductive rights with David Hackney, MD, MS
December 20th 2022In this episode of Pap Talk, we spoke with David Hackney, MD, MS, maternal-fetal medicine physician at Case Western Reserve University and chair of ACOG's Ohio chapter for a full recap of where restrictions on reproductive rights have been and where they're going.
Listen
CooperSurgical unveils new inserter for simplified Paragard IUD placement
September 4th 2024The new single-handed inserter by CooperSurgical streamlines the placement of Paragard, a hormone-free IUD with over 30 years of proven efficacy, enhancing accessibility for both health care providers and patients.
Read More
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
How the mifepristone case highlights the need to protect reproductive health care
August 13th 2024Following the Supreme Court’s decision to retain mifepristone access in June 2024, health care providers have spoken out about the need to fight for reproductive health care protections on a national and local level.
Read More